CACNB2

gene product
CACNLB2, MYSB
This gene encodes a subunit of a voltage-dependent calcium channel protein that is a member of the voltage-gated calcium channel superfamily. The gene product was originally identified as an antigen target in Lambert-Eaton myasthenic syndrome, an autoimmune disorder. Mutations in this gene are associated with Brugada syndrome. Alternatively spliced variants encoding different isoforms have been described. [provided by RefSeq, Feb 2013]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated within AVI
Eligible for validation within AVI
551 antibodies from 31 providers.

Antibody properties

General

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
Novus Biologicals
27 antibodies
antibodies-online
183 antibodies
Abnova Corporation
7 antibodies
LifeSpan BioSciences, Inc.
100 antibodies
GeneTex
16 antibodies
Antibodies Incorporated
2 antibodies
OriGene
19 antibodies
Invitrogen Antibodies
6 antibodies
Atlas Antibodies
2 antibodies
Biorbyt
30 antibodies
NovoPro Bioscience Inc.
4 antibodies
Abgent
4 antibodies
Antibodies.com
1 antibody
Acris Antibodies GmbH
3 antibodies
FabGennix
6 antibodies
Everest Biotech
1 antibody
NSJ Bioreagents
1 antibody
Proteintech Group
1 antibody
Aviva Systems Biology
14 antibodies
ProSci
7 antibodies
Creative Biolabs
8 antibodies
UC Davis/NIH NeuroMab Facility
2 antibodies
Creative Diagnostics
3 antibodies
St John's Laboratory
1 antibody
MyBioSource
4 antibodies
United States Biological
75 antibodies
GenWay
2 antibodies
Sigma-Aldrich
8 antibodies
EMD Millipore
1 antibody
Exalpha Biologicals, Inc.
1 antibody